Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMRN |
---|---|---|
09:32 ET | 8627 | 85.49 |
09:34 ET | 5513 | 84.88 |
09:36 ET | 700 | 85.14 |
09:38 ET | 1200 | 85.25 |
09:39 ET | 573 | 84.84 |
09:41 ET | 1100 | 84.965 |
09:43 ET | 900 | 84.98 |
09:45 ET | 2600 | 85.05 |
09:48 ET | 26627 | 85.27 |
09:50 ET | 2280 | 85.46 |
09:52 ET | 1900 | 85.43 |
09:54 ET | 1380 | 85.335 |
09:56 ET | 200 | 85.26 |
09:57 ET | 1590 | 85.13 |
09:59 ET | 300 | 85.02 |
10:01 ET | 920 | 85 |
10:03 ET | 1923 | 85.06 |
10:06 ET | 5052 | 85.16 |
10:08 ET | 200 | 85.14 |
10:10 ET | 500 | 85.05 |
10:12 ET | 700 | 85.19 |
10:14 ET | 2125 | 85 |
10:15 ET | 1605 | 85.06 |
10:17 ET | 5235 | 85.335 |
10:19 ET | 2631 | 85.325 |
10:21 ET | 1000 | 85.4 |
10:24 ET | 2787 | 85.21 |
10:26 ET | 1849 | 85.29 |
10:28 ET | 1500 | 85.34 |
10:30 ET | 5700 | 85.38 |
10:32 ET | 11931 | 84.9926 |
10:33 ET | 300 | 84.97 |
10:37 ET | 680 | 84.82 |
10:39 ET | 3323 | 84.98 |
10:42 ET | 1057 | 85.02 |
10:46 ET | 200 | 84.96 |
10:48 ET | 200 | 84.96 |
10:50 ET | 100 | 85.01 |
10:51 ET | 1700 | 84.9 |
10:53 ET | 500 | 84.785 |
10:55 ET | 1300 | 84.795 |
10:57 ET | 2060 | 84.965 |
11:00 ET | 2618 | 84.85 |
11:02 ET | 300 | 84.78 |
11:04 ET | 2277 | 84.765 |
11:08 ET | 2318 | 84.545 |
11:09 ET | 2494 | 84.68 |
11:11 ET | 300 | 84.68 |
11:13 ET | 1022 | 84.69 |
11:15 ET | 800 | 84.73 |
11:18 ET | 250 | 84.69 |
11:20 ET | 1600 | 84.5 |
11:22 ET | 1623 | 84.6 |
11:24 ET | 500 | 84.66 |
11:27 ET | 1362 | 84.72 |
11:29 ET | 1132 | 84.81 |
11:31 ET | 1200 | 84.9 |
11:33 ET | 1563 | 84.87 |
11:36 ET | 1000 | 84.755 |
11:38 ET | 1000 | 84.84 |
11:40 ET | 854 | 84.88 |
11:42 ET | 600 | 84.89 |
11:44 ET | 317 | 84.89 |
11:45 ET | 100 | 84.85 |
11:47 ET | 1200 | 84.83 |
11:49 ET | 2121 | 84.78 |
11:51 ET | 13711 | 84.68 |
11:54 ET | 3042 | 84.65 |
11:56 ET | 1507 | 84.59 |
11:58 ET | 800 | 84.65 |
12:00 ET | 1400 | 84.71 |
12:02 ET | 2200 | 84.775 |
12:03 ET | 9840 | 84.785 |
12:05 ET | 5500 | 84.745 |
12:07 ET | 5875 | 84.78 |
12:09 ET | 9902 | 84.7 |
12:12 ET | 1324 | 84.625 |
12:14 ET | 500 | 84.53 |
12:16 ET | 1300 | 84.455 |
12:18 ET | 1200 | 84.445 |
12:20 ET | 1058 | 84.465 |
12:21 ET | 1500 | 84.42 |
12:23 ET | 1200 | 84.29 |
12:25 ET | 1897 | 84.25 |
12:27 ET | 1481 | 84.295 |
12:30 ET | 1591 | 84.35 |
12:32 ET | 1125 | 84.3075 |
12:34 ET | 2598 | 84.26 |
12:36 ET | 2669 | 84.29 |
12:38 ET | 1020 | 84.295 |
12:39 ET | 4432 | 84.2 |
12:41 ET | 300 | 84.25 |
12:43 ET | 1729 | 84.39 |
12:45 ET | 900 | 84.36 |
12:48 ET | 300 | 84.275 |
12:50 ET | 1363 | 84.205 |
12:52 ET | 1312 | 84.235 |
12:54 ET | 1177 | 84.2 |
12:56 ET | 200 | 84.205 |
12:57 ET | 8770 | 84.15 |
12:59 ET | 2264 | 84.225 |
01:01 ET | 4005 | 84.282 |
01:03 ET | 2218 | 84.27 |
01:06 ET | 1000 | 84.38 |
01:08 ET | 1100 | 84.4 |
01:10 ET | 700 | 84.39 |
01:12 ET | 305 | 84.395 |
01:14 ET | 2127 | 84.31 |
01:15 ET | 900 | 84.29 |
01:17 ET | 1600 | 84.19 |
01:19 ET | 3250 | 84.235 |
01:21 ET | 2180 | 84.29 |
01:24 ET | 2323 | 84.215 |
01:26 ET | 1100 | 84.215 |
01:28 ET | 1800 | 84.21 |
01:30 ET | 800 | 84.26 |
01:32 ET | 500 | 84.26 |
01:33 ET | 2235 | 84.25 |
01:35 ET | 2800 | 84.155 |
01:37 ET | 1892 | 84.175 |
01:39 ET | 1800 | 84.22 |
01:42 ET | 2100 | 84.38 |
01:44 ET | 4099 | 84.36 |
01:46 ET | 1635 | 84.415 |
01:48 ET | 13900 | 84.435 |
01:50 ET | 2000 | 84.465 |
01:51 ET | 911 | 84.61 |
01:53 ET | 7607 | 84.65 |
01:55 ET | 900 | 84.79 |
01:57 ET | 2889 | 84.83 |
02:00 ET | 500 | 84.9 |
02:02 ET | 2327 | 84.94 |
02:04 ET | 707 | 84.995 |
02:06 ET | 900 | 84.94 |
02:08 ET | 101 | 84.98 |
02:09 ET | 300 | 84.96 |
02:11 ET | 300 | 84.965 |
02:13 ET | 1000 | 84.94 |
02:15 ET | 2961 | 84.85 |
02:18 ET | 300 | 84.85 |
02:20 ET | 2011 | 84.84 |
02:22 ET | 1300 | 84.8 |
02:24 ET | 689 | 84.79 |
02:26 ET | 1250 | 84.81 |
02:27 ET | 1200 | 84.81 |
02:29 ET | 400 | 84.83 |
02:31 ET | 757 | 84.82 |
02:36 ET | 2100 | 84.95 |
02:38 ET | 2200 | 84.9206 |
02:42 ET | 809 | 84.93 |
02:44 ET | 1300 | 84.91 |
02:45 ET | 1576 | 84.94 |
02:47 ET | 400 | 84.945 |
02:49 ET | 300 | 84.95 |
02:51 ET | 1250 | 84.97 |
02:54 ET | 1801 | 84.96 |
02:56 ET | 1709 | 84.91 |
02:58 ET | 1300 | 84.97 |
03:00 ET | 909 | 84.855 |
03:02 ET | 800 | 84.86 |
03:03 ET | 808 | 84.89 |
03:05 ET | 1328 | 84.77 |
03:07 ET | 2227 | 84.88 |
03:09 ET | 800 | 84.895 |
03:12 ET | 2085 | 84.97 |
03:14 ET | 600 | 84.96 |
03:16 ET | 700 | 84.91 |
03:18 ET | 200 | 84.92 |
03:20 ET | 800 | 84.94 |
03:21 ET | 300 | 84.935 |
03:23 ET | 400 | 84.95 |
03:25 ET | 2482 | 85 |
03:27 ET | 1830 | 85.03 |
03:30 ET | 3828 | 84.975 |
03:32 ET | 4672 | 84.9225 |
03:34 ET | 3566 | 85.01 |
03:36 ET | 1848 | 85.04 |
03:38 ET | 381 | 85.03 |
03:39 ET | 1857 | 85.01 |
03:41 ET | 1554 | 85.015 |
03:43 ET | 2300 | 85.02 |
03:45 ET | 3119 | 84.935 |
03:48 ET | 3617 | 84.97 |
03:50 ET | 5380 | 84.99 |
03:52 ET | 4044 | 85.07 |
03:54 ET | 4076 | 85 |
03:56 ET | 10052 | 84.9 |
03:57 ET | 30361 | 84.67 |
03:59 ET | 270377 | 84.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomarin Pharmaceutical Inc | 16.3B | 79.0x | --- |
Beigene Ltd | 17.4B | -21.5x | --- |
United Therapeutics Corp | 14.9B | 16.0x | +8.22% |
Neurocrine Biosciences Inc | 14.7B | 40.3x | +62.04% |
Exact Sciences Corp | 8.9B | -34.2x | --- |
Medpace Holdings Inc | 11.8B | 35.9x | +35.10% |
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.3B |
---|---|
Revenue (TTM) | $2.5B |
Shares Outstanding | 189.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.31 |
EPS | $1.07 |
Book Value | $26.25 |
P/E Ratio | 79.0x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | 52.3x |
Operating Margin | 7.09% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.